Benchmarking, accountability, bilateralism, and scalability are the 4 parameters critical to successful alternative payment models in oncology, said Aaron Lyss, MBA, director of strategy and business development at Tennessee Oncology.
Benchmarking, accountability, bilateralism, and scalability are the 4 parameters critical to successful alternative payment models in oncology, said Aaron Lyss, MBA, director of strategy and business development at Tennessee Oncology.
Transcript:
What would you like to see in the next iteration of a payment model for oncology?
I think there are 4 parameters that are critical to alternative payment models in oncology. The first is benchmarking. Are the performance benchmarks associated with the model achievable and reasonable for the practices who are participating? I think the second important issue is control and accountability. By that,I mean, does a practice, do providers have control over the outcomes of the model? Can they then be held accountable for their performance? Then I think the third issue is what I'll refer to as bilateralism. That's basically, is the payment structure of the model suitable both to the provider group as well as to the payer, based on the value that the practice can create in the model? Then the fourth issue is scalability. Does the model apply to a broad enough population of patients that enables the practice to focus on all the improvements in care delivery that they want to see across a very broad population? Then from the payer perspective, does the model work for a broad enough population of practices that it can apply to a nationwide cohort of practices who would be participating?
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Latest Advances and Updates of Treatment in the Real World at AUA
May 1st 2024The annual meeting of the American Urological Association (AUA) not only presents the newest therapies coming out but showcases the latest in how treatments are being used in the real world, said Stephen Freedland, MD, of Cedars Sinai.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More